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Abstract
The standard expression quantitative trait loci (eQTL) detects polymorphisms associated with gene
expression without revealing causality. We introduce a coupled Bayesian regression approach—eQTeL, which
leverages epigenetic data to estimate regulatory and gene interaction potential, and identifies combination of
regulatory single-nucleotide polymorphisms (SNPs) that explain the gene expression variance. On human
heart data, eQTeL not only explains a significantly greater proportion of expression variance but also predicts
gene expression more accurately than other methods. Based on realistic simulated data, we demonstrate that
eQTeL accurately detects causal regulatory SNPs, including those with small effect sizes. Using various
functional data, we show that SNPs detected by eQTeL are enriched for allele-specific protein binding and
histone modifications, which potentially disrupt binding of core cardiac transcription factors and are spatially
proximal to their target. eQTeL SNPs capture a substantial proportion of genetic determinants of expression
variance and we estimate that 58% of these SNPs are putatively causal.
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Bayesian integration of genetics and epigenetics
detects causal regulatory SNPs underlying
expression variability
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The standard expression quantitative trait loci (eQTL) detects polymorphisms associated
with gene expression without revealing causality. We introduce a coupled Bayesian regression
approach—eQTeL, which leverages epigenetic data to estimate regulatory and gene inter-
action potential, and identiﬁes combination of regulatory single-nucleotide polymorphisms
(SNPs) that explain the gene expression variance. On human heart data, eQTeL not only
explains a signiﬁcantly greater proportion of expression variance but also predicts gene
expression more accurately than other methods. Based on realistic simulated data, we
demonstrate that eQTeL accurately detects causal regulatory SNPs, including those with small
effect sizes. Using various functional data, we show that SNPs detected by eQTeL are
enriched for allele-speciﬁc protein binding and histone modiﬁcations, which potentially
disrupt binding of core cardiac transcription factors and are spatially proximal to their target.
eQTeL SNPs capture a substantial proportion of genetic determinants of expression variance
and we estimate that 58% of these SNPs are putatively causal.
DOI: 10.1038/ncomms9555 OPEN
1 Center for Bioinformatics and Computational Biology, University of Maryland, College Park, Maryland 20742, USA. 2 Perelman School of Medicine,
University of Pennsylvania, Philadelphia, Pennsylvania 19104-5159, USA. 3 Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland
Clinic, Cleveland, Ohio 44195, USA. 4 The Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-5159, USA. 5 The Wharton School, University
of Pennsylvania, Philadelphia, Pennsylvania 19104-6340, USA. wA full list of consortium members appears at the end of the paper. Correspondence and
requests for materials should be addressed to A.D. (email: vinash85@umiacs.umd.edu) or to S.H. (email: sridhar@umiacs.umd.edu).
NATURE COMMUNICATIONS | 6:8555 | DOI: 10.1038/ncomms9555 | www.nature.com/naturecommunications 1
& 2015 Macmillan Publishers Limited. All rights reserved.
N
umerous expression quantitative trait loci (eQTL) studies
have been performed to determine the cell-type-speciﬁc
regulatory architecture of the human genome1. However,
since single-nucleotide polymorphisms (SNP) within a linkage
disequilibrium (LD) region are statistically indistinguishable from
each other, these studies essentially reveal LD blocks that are
associated with a gene expression but do not reveal the potential
causative regulatory SNPs, which limits the utility of these
studies2–6. The recent explosion of epigenetic data has made it
possible to detect cell-type-speciﬁc regulatory regions5–9, which
can be used to distinguish regulatory SNPs from non-regulatory
SNPs in LD blocks.
Recently, a few approaches have incorporated regulation
speciﬁc epigenetic data into association studies5–10. However, to
prioritize eQTL SNPs, these methods have utilized the regulatory
information either retrospectively or to estimate an empirical
prior probability for the SNPs. Such approaches are prone to
missing regulatory SNPs with small effects due to the severe
multiple testing correction (or sparsity constraints)1.
Furthermore, these approaches ignore interaction between the
region harbouring the SNP and the target gene, which is useful in
identifying regulators speciﬁc to a gene. Multiple SNPs are known
to regulate single genes11, yet many current methods8,9,11 limit
the number of causal SNPs per gene to a single SNP. In this
paper, we introduce a new method, expression quantitative trait
enhancer loci (eQTeL), which addresses these limitations. It
identiﬁes combination of regulatory SNPs—including SNPs with
small effect sizes—that jointly determine expression variance.
eQTeL is a fully Bayesian approach (Fig. 1), which infers cis
regulatory polymorphisms underlying gene expression variability
by integrating: (i) genotype and gene-expression variance across
individuals; (ii) epigenetic data in appropriate cell types10,12;
(iii) DNAse I hypersensitivity (DHS) variance of SNPs and
promoters across cell types13; (iv) expression variance of genes
across multiple cell types; (v) LD blocks14; and (vi) imputed
haplotypes inferred from the 1,000 Genomes Project15. Our
approach addresses a number of key methodological challenges.
First, it systematically integrates three characteristics of a causal
regulatory eQTL, that is, correlation with the target genes
expression across individuals, the regulatory properties of the
harbouring region, and interaction with the target gene. Second, it
can account for heterogeneity of regulatory regions in terms of
different combinations of epigenetic marks. Third, to learn the
regulatory model, eQTeL leverages regulatory polymorphisms
that are not associated with gene expression in addition to
expression-regulators. Fourth, it interrogates the LD structure to
ﬁnd the optimal combination of explanatory SNPs. Fifth, it
implements a hierarchical scheme to select a sparse set of SNPs,
while simultaneously explaining a maximal fraction of gene
expression variance. Finally, eQTeL is scalable to large datasets.
We statistically validated our method using human heart data
as well as realistic simulated data and demonstrated that it can
predict an individual’s expression from the genotype more
accurately compared to other methods. SNPs identiﬁed by our
method include regulatory SNPs with small effect sizes. Further
assessment of functional relevance of identiﬁed SNPs suggest that
they tend to (i) overlap a high resolution DNAse footprint,
(ii) have an allele-speciﬁc DNAse footprint, (iii) preferentially
disrupt putative binding of core cardiac regulators and (iv) be
spatially proximal to their putative target gene. We also estimate
Input
SNP
Expression
model
Expression model
Epigenetics and
interaction
LD block
eQTeL
Regulatory
model
Regulatory model
Expression
Output
(i) Regulatory
Variants (eeSNP)
(ii) Effect size
(iii) Regulatory
and interction
potntial
(iv) Epigenetics
and interaction
importance
For each gene
SNP
LD
LD LD LD
Expression
regulators
Regulatory and
interction
potentials
Interacting
regulators
Epigenetics
+
interaction
Feature
importance
a b
Figure 1 | Overview of eQTeL model. (a) Input and output of eQTeL. eQTeL takes genotype and gene expression across samples, epigenetic and interaction
features for each SNP and LD block as input. It outputs regulatory SNPs and their target genes, their effect sizes and regulatory-interaction potentials, as
well as estimated feature importance of each epigenetic and interaction feature. (b) eQTeL is composed of two coupled regression models (i) a Bayesian
variable selection with informative priors models expression as a linear combination of SNPs. Given the regulatory and interaction priors, this hierarchical
model ﬁrst identiﬁes LD blocks and then combinations of SNPs that explains expression variance and that also have high regulatory and interaction
potentials. (ii) A Bayesian logistic regression speciﬁes the regulatory and interaction potential as linear model of epigenetic and interaction features in
semi-supervised manner. The logistic regression passes the regulatory and interaction potentials to the variable selection model, while the variable
selection model passes expression-regulators to the logistic regression model.
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that 58% of SNPs identiﬁed by eQTeL (which we call eeSNPs,
Supplementary Data 1) are likely to be causal. Collectively, these
results strongly suggest that eeSNPs have functional role.
Results
Quantitative Trait enhancer Loci (eQTeL) model. We ﬁrst
provide a broad overview of the eQTeL model and further details
can be found in Methods. As illustrated in Fig. 1, eQTeL is
composed of two Bayesian regression models, an expression
model and a regulatory model, which are coupled through
message passing. The expression model is a Bayesian variable
selection model16,17 which explains the gene expression variance
among samples as a linear function of SNP alleles. A distinct
feature of the expression model is that it uses informative prior
for each SNP, which depends on the SNPs regulatory6 and
interaction potential. The regulatory model, which is common for
all genes, uses a Bayesian logistic regression18 to estimate that
informative prior as a probabilistic function of epigenetic and
interaction features. Known expression regulators can be used to
train the regulatory model, while an accurate model of regulatory
and interaction potential can help to identify expression
regulators. The expression model then passes current estimates
of expression regulators to the regulatory model, which in passes
current estimates of regulatory and interaction priors for each
SNP back to the expression model. eQTeL starts with estimating
expression regulators assuming equal priors for each SNP and
then, using current estimates of expression-regulators, trains the
regulatory-model. In turn, current estimates of regulatory and
interaction potential are used as informative priors to re-estimate
expression regulators. This iterative process continues until
convergence. Thus, our eQTeL model gradually improves
estimation accuracy by joint learning.
In our approach (see equations below and Methods for details),
expression Y relates to candidate SNPs X via a standard normal
linear model16,19,20 with noise s2. However, for each SNP b, its
effect size is non-zero only if its regulatory-interaction indicator g
is 1, which depends on a function f0(y) of regulatory-interaction
potential y (Methods). The potential y of a SNP is modelled
as a combination of (i) features for regulatory potential and
(ii) features for SNP-gene interaction P, via a logistic function.
Vector a represents feature weights that are shared across all
genes, thus we learn a single genome-wide model of regulators.
This choice of modelling a obviates the need to explicitly scale
genetic and epigenetic factors.
Y  N Xc  bc; s2I
 
g  Bern f yð Þð Þ 8SNPs
y  Bern logistic E;Pf g  aÞð Þ 8SNPsð
We use Markov chain Monte Carlo21 to infer all model
parameters jointly (Supplementary Note 1). At each iteration of
the sampler, the decision whether a region is a regulator (that is,
y¼ 1) depends not only on correlation between corresponding
SNP and gene but also on the regulatory and interaction features,
as well as the current estimates of feature weights. This leads to a
semi-supervised22,23 clustering of SNPs into regulators and non-
regulators (Supplementary Note 1). Our Markov chain Monte
Carlo implementation explicitly uses LD24 block information to
judiciously choose combination of regulatory SNPs by sampling
over the model space hierarchically21 at the top level it explores
combinations of LD blocks and at the lower level it explores the
sparse set of SNPs within each LD block that optimally explain
the expression-variance (Fig. 1, Methods, Supplementary Note 1,
Supplementary Fig. 1). This approach results in a superior
exploration of the model space relative to approaches that
disregard the LD structure. eQTeL uses a Rao–Blackwell estimate
of y that improves the mixing rate (Supplementary Fig. 1) of the
sampler and leads to robust competition between SNPs within a
LD block (Fig. 1). Further, the overall sparsity constraint
(equivalent to a multiple testing correction in non-Bayesian
approaches) of eQTeL is controlled by two factors: (i) the fraction
of SNPs that are interacting-regulators and (ii) the fraction of
interacting-regulators that are expression-regulators. This allows
for a less conservative sparsity constraint and makes it possible to
identify SNPs with small effect sizes which are typically missed
by alternative approaches because of severe multiple testing
correction. eQTeL assumes Normal priors on a. Finally, eQTeL
implementation allows an option to select a subset of epigenetic
factors important for estimating regulatory potential through
Bayesian variable selection model.
eQTeL detects expression regulatory SNP in MAGNet. We
applied eQTeL to genotype and gene expression data for 313
human hearts (procured by MAGNet consortium (www.med.
upenn.edu/magnet/)) and compared with the performance of
other eQTL methods (Supplementary Notes 2 and 3). To deter-
mine regulatory and interaction potentials, we used 95 epigenetic
and interaction features (Supplementary Fig. 2) for primary
tissues and cell lines of heart from ENCODE and Roadmap
Epigenome project10,12. For expediency we selected 1,880 genes
with expression deemed to have a signiﬁcant genetic component
according to the univariate eQTL11,25.
Consistent with its ability to explain a greater expression
variance, eQTeL also predicts expression of genes much more
accurately compared with other methods (Fig. 2b). The mean
(cross-validated) Pearson correlation coefﬁcient between pre-
dicted and actual expression is 0.176±0.065 (in contrast with
0.025 for eqtnminer8 and 0.088 for LASSO26). The bimodality of
distribution of correlation coefﬁcient implies that for a subset of
genes, the expressions are highly predictable by eQTeL.
Because of its ability to discriminate among multiple SNPs
based on regulatory and interaction potentials, eQTeL is expected
to be much more advantageous on imputed data, which has a
substantially greater number of linked SNPs. To conﬁrm this, we
imputed27 B6.5 million SNPs using the 1,000 Genome Project
data15. Note that each imputed SNP is derived from the reference
SNPs using the linkage information, and cannot be any more
associated (in a statistical sense) with the gene expression than the
reference SNPs, and therefore are not expected to increase the
explained variance (as evident from Fig. 2c). However, eQTeL
with imputation is expected to improve detection of causal
functional SNPs compared with the genotyped SNPs10,11.
Therefore, restricting our search to potentially functional SNPs,
imputed SNPs should explain the expression better. Restricting
our analysis only to SNPs mapped to a DNAse footprint (as a
proxy for putative functional SNPs), the relative advantage of
imputation with eQTeL becomes evident (Fig. 2c). Indeed, with
imputed data, there is no signiﬁcant improvement in detection of
likely causal SNPs if standard eQTL approaches are used.
Therefore it becomes imperative to use an integrative approach,
such as eQTeL, in the presence of a large number of linked SNPs
(Fig. 2c).
To validate eeSNPs in an independent cohort, we analysed
expression and genotype of 85 left ventricle samples from GTEx1
(Supplementary Note 2). We note that compared to an exhaustive
eQTL, eQTeL cannot identify novel associated loci, but instead is
designed to identify putatively causal SNPs within an associated
locus. We found that 18.9% of eGenes detected in MAGNet
replicates in GTEx (Supplementary Data 2). To assess the relative
generalizablity of eQTeL in independent cohort, using the eeSNPs
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identiﬁed by eQTeL in MAGNet, we estimated the explained
variance in GTEx. We repeated this for other methods while
controlling for the number of eeSNPs as well as other
regularization procedures. While, as expected due to the
differences in the datasets, the cross-cohort explained variance
is lower than that within MAGNet (Fig. 2b versus 2d), relative to
other methods, eQTeL exhibits substantially and signiﬁcantly
greater (in both cases Wilcoxon test P value between eQTeL and
other methods is o1.0 10 16) cross-data set generalizability
(Fig. 2d, Supplementary Fig. 3).
eQTeL detects causal SNPs in semi-synthetic data. To demon-
strate that eQTeL can accurately identify putatively causal SNPs,
we use a synthetic data evaluation (Fig. 3a) (for additional details
refer to Methods). We used 174,800 SNP probes along with their
genotypes from 313 MAGNet samples that were within 1MB
from transcription start of 200 genes (Methods). Since regulatory
region may have no effect on genes included in our analyses and
yet can contribute to learning the regulatory-model, eQTeL
makes a distinction between a regulator and a gene-speciﬁc
expression-regulator. This distinction was made explicitly in our
simulation by designating 1% of all SNPs as regulators (as an
approximation of previous estimation in humans28). We then
used a frequency distribution of expression regulators per gene
inferred from MAGNet data to randomly choose gene-speciﬁc
expression-regulators for 200 genes. Using allele status of 313
samples for expression-regulators, we generated gene expression
and added random noise such that expected explained variance
from simulated data matched MAGNets explained variance
(Fig. 2a). We generated the epigenetic features for each SNP
using ENCODE epigenetic data and validated heart-enhancers
from VISTA6. Thus our simulated data closely parallels the
experimental data.
Next we applied eQTeL to the simulated data. The precision-
recall plot (Fig. 3b) shows that eQTeL signiﬁcantly outperforms
other methods. In fact, the performance of full-eQTeL is close
to the theoretically best eQTeL model that uses the original
feature weights (see Methods). The previous integrative method
eqtnminer8,9, the only other current method that uses epigenetic
data in eQTL, shows only a modest increase in precision
compared to methods that do not use epigenetic data.
The immediate effect of increase in precision of detecting
expression regulators, especially for SNPs with high regulatory
potential, is that eQTeL explains a signiﬁcantly greater proportion
of expression variability (Supplementary Fig. 4). There is also
signiﬁcant improvement in correlation between predicted expres-
sion and actual gene expression; mean correlation for eQTeL was
0.298  þ 0.02 (compared with 0.18 for eqtnminer and 0.23
for LASSO regression, Supplementary Fig. 5). Note that for this
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Figure 2 | Comparative performance of different methods applied to human heart data (MAGNet). The analysis is based on 2428 SNPs identiﬁed by
eQTeL for which posterior probability of selection40.5. To ensure the same total number of SNPs selected by eQTeL, eqtnminer and LASSO: for eqtnminer
we sort SNPs based on posterior probability and for LASSO based on absolute estimated effect size and then selected top 2,428 SNPs. (a) Explained
expression variance based on three representative methods on human heart data. (b) Accuracy of predicted expression of three methods. (c) Explained
expression variance for human heart data by potentially functional (approximated by overlap with a footprint) genotyped SNPs and imputed SNPs.
(d) Cross-data set generalization of MAGNet eeSNPs: expression predictability in GTEx by eeSNPs identiﬁed in MAGNet.
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analysis we controlled for the number of SNPs that were selected
for each method, using the most explanatory respective SNPs for
each method. Overall, eQTeL can accurately identify around 75%
of putative causal SNPs (at 40% recall) reinforcing the fact that
our method can identify substantial fraction of likely causal
genetic determinants of transcriptomic variance.
eQTeL detects SNPs with small effect sizes. The statistical power
to detect SNPs associated with expression variance (that is, the
probability of correctly rejecting the null hypothesis that the SNP
is not associated with gene expression) depends on various factors
such as sample size, noise to signal ratio, number of hypothesis
tested (number of SNPs) and effect size of SNP. The effect size, in
turn, depends on the allele frequency of SNP, thus low allele
frequency limits statistical power to detect regulatory SNPs1,29.
Another advantage of eQTeL model is that it can detect
SNPs with small effect sizes by distributing sparsity between:
(a) sparsity in the number of regulators and, (b) sparsity in
expression regulators among all regulators. eQTeL employs
relatively relaxed sparsity constraints for SNPs that have high
regulatory potential and therefore the model has higher statistical
power to retrieve a greater fraction of SNPs with low minor allele
frequency (small effect sizes) compared to eqtnminer (Fig. 4).
Furthermore, eQTeLs statistical power to identify low minor
allele frequency SNPs is greater among SNPs with high
regulatory-interacting potential (labelled as eQTeL-high in
Fig. 4). This trend of differential statistical power is also
observed in simulated data, where we know the exact effect size
of regulatory SNPs (Supplementary Fig. 6).
eQTeL leverages LD information to judiciously choose
combinations of SNPs (per gene) which explains a much greater
proportion of expression variance (details in Supplementary
Note 2). The power to detect SNPs with low allele frequency is the
primary reason that eQTeL captures substantial proportion of
causal genetic determinants underlying transcriptomic variance.
However, it should be noted that SNPs with small effect sizes are
only detected by eQTeL if they have a high regulatory potential.
eQTeLs performance gain is potentially due to two factors:
(i) integration of epigenetic data, (ii) allowing multiple causal
variants per gene30. We assessed relative contribution of the two
factors. eQTeLs expression predictability by functional SNPs
increases substantially when multiple SNPs per gene were allowed
(Supplementary Fig. 7, Supplementary Note 2), supporting a
contribution due to multiple explanatory SNPs. However, in the
absence of epigenomic data, that is, when using standard LASSO,
we do not see a performance gain, and in general, the
performance is substantially worse than the performance of
eQTeL. This suggests that allowing multiple SNPs per gene is
useful speciﬁcally when functional information is used.
eeSNPs lie within protein-bound genomic regions. Putative
causal regulatory SNPs are expected to be bound by regulatory
proteins. Earlier studies have shown enrichment of regulatory
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Figure 3 | eQTeL identify causal SNP accurately in semi-simulated data.
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from MAGNet Genotype (874 SNPs per gene) data for 313 samples,
(ii) distribution of number of expression-regulators per gene from MAGNet
data, (iii) distribution of explained expression variance estimated from
MAGNet data, (iv) ENCODE epigenetic data for heart cell lines and
(v) distribution of epigenetic data for regulators VISTA heart enhancers.
Expression regulators per gene were chosen amongst regulators (1% of
MAGNet SNPs). Using allele status of expression regulators in 313 samples
expression of 200 genes was generated such that explained variance
distribution matches MAGNets explained variance. Epigenetic data for
regulators were generated using the epigenetic distribution estimated from
VISTA heart enhancers. (b) Comparative performance assessment on
simulated data. Methods include (i) Matrix-eQTL11,25 (univariate-eQTL):
univariate regression, (ii) LASSO44: L1 regularizer multivariate regression,
(iii) variable selection17: Bayesian variable selection, (iv) eqtnminer8:
Bayesian variable selection with empirical-priors, (v) epigenetic-only:
epigenetic feature weights derived from veriﬁed enhancers and used to
prioritize SNPs, (vi) eQTeL: proposed method and (vii) known-epigenetic-
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Figure 4 | eQTeL increase statistical power to detect small-effect
regulatory SNPs: comparsion of effect-size of SNPs detected by eQTeL
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elements near causal SNPs7–9,11. Since eQTeL and eqtnminer use
epigenetic data, which is known to be correlated10 with protein
binding, we expect to ﬁnd enrichment of DNAse footprints
near the identiﬁed regulatory SNPs. Using genome-wide high-
resolution DNAse footprint data for 41 cell types31, we obtained
the fraction of eeSNPs (and control SNPs) overlapping with a
footprint; Note that DNAse footprints were not used in eQTeL so
they could be used for validation. 76.3% of eeSNP have a
footprint overlapping the eeSNP (Fig. 5), in contrast to 6.3% of in
SNPs detected by eqtnminer that uses same epigenetic data as
eQTeL. The performance of eqtnminer did not improve even if
the best SNP per gene were chosen for this analysis. For SNPs
chosen by LASSO, which does not use epigenetic data, only 5.95%
of SNPs have overlapping DNAse footprints. Only 2% of SNPs
identiﬁed by Lirnet (for 200 genes) overlap with the DNAse
footprints (Supplementary Fig. 8). Using top 8 epigenetic features
estimated from eQTeL allowed to improve performance of
eqtnminer, but could not bring it up to eeSNPs enrichment level
(Supplementary Fig. 9 and Supplementary Note 4). Notably, the
DNAse footprint enrichment is high in the four heart-related cell
types. This result suggests that majority of SNPs identiﬁed by
eQTeL coincide with regions of in vivo protein binding and are at
least 12-fold more likely to be functional than the next closest
method.
eeSNPs exhibit binding and regulatory allele speciﬁcity. To
ascertain the functional role of eeSNPs, we checked whether the
change of a SNPs allele would affect their regulatory properties
(such as protein binding, histone modiﬁcations and so on).
For each cell line, we selected heterozygous SNPs by inspecting
genotyped data or pooled reads from different histone
modiﬁcations, DNAse-seq and CTCF. We ﬁrst assessed allelic
differences in footprint reads for human cardiac myocyte (HCM)
(see Methods). As shown in Fig. 6, the eeSNPs that overlap a
footprint show signiﬁcantly greater (with odd-ratio of M¼ 3.005
and P value o3.83 10 17) allele-speciﬁcity relative to SNPs
identiﬁed by eqtnminer, consistent with eeSNP having a reg-
ulatory impact (allele-speciﬁty comparison with LASSO is shown
in Supplementary Fig. 10). For eeSNPs, we obtained 6.57-fold
more reads mapping to the allele with more DNA-seq reads
compared with the other allele (for eqtnminer, the average read
difference was 1.8). We also found higher allele speciﬁcity for
eeSNPs in other heart cell lines (Supplementary Fig. 11, HCF,
SKMC) for DNASe-Seq reads. The trend of higher allelic
speciﬁcity is also true in heart cell lines for histone modiﬁcation
H3K4me3, which is associated with active enhancers
(Supplementary Fig. 12). Allele-speciﬁcity of eeSNPs suggests that
they may underlie population variance in gene expression.
eeSNPs are spatially proximal to their target gene. The spatial
proximity of eeSNP with its target promoter is a pre-requisite
for cis-regulation. Spatial proximity has been experimentally
determined using chromatin interaction analysis with paired-end
tags (ChIA-PET) assays32. Identiﬁed SNPs that were closer than
100 bps from their target promoters were excluded. We quantiﬁed
spatial proximity of each eeSNP and its target by the number of
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pair-end reads supporting the proximity, whereby one of the
reads overlaps with the target promoter and other read overlaps
with the eeSNP. Analysis of pooled ChIA-PET data from various
cell types suggests that, relative to controls, eeSNPs are
signiﬁcantly more proximal to their target genes (Fig. 7). This
implies that eeSNPs are more likely to be cis-regulators of their
target genes.
eeSNPs disrupt motifs of cardiac transcription factors. A likely
mechanism by which a regulatory SNP may affect gene expres-
sion is by disrupting binding of speciﬁc transcription factors33.
For each of the 981 vertebrate TF motifs annotated in the
TRANSFAC database34, we quantiﬁed (see Methods) the TF
binding score difference between two alleles of eeSNP. We only
considered the SNPs for which the score was signiﬁcant for at
least one of the alleles. As shown in Fig. 8, the core cardiac TF
motifs (such as FOX, NKX, GATA) are among the TF binding
motifs that are most likely to be disrupted by eeSNPs. This
observation indicates that functional consequence of regulatory
SNP might be heart speciﬁc. The disruption of STAT,
MEF2, FOX, NKX and GATA transcription factor families are
known to play important role in cardiovascular diseases6,35–37.
This suggests that identiﬁed eeSNPs may have a speciﬁc
transcriptional role in the heart.
Proportion of eeSNPs that are causal. In the absence of exten-
sive experimental data, it is difﬁcult to estimate the proportion
of eeSNPs that are causal. However, similar to a previous
approach11, we used the proportion of eeSNPs that disrupt
potential TF binding relative to the same for high-conﬁdence
putatively causal SNPs, as an independent estimate of proportion
of eeSNPs likely to be causal (see Methods). Based on each
TF motif, that was found to be preferentially disrupted by
eeSNPs above, the proportion of eeSNPs estimated to be
causal varied from 17 to 93%, with a mean estimate of 58%
(Methods, Supplementary Fig. 12). Lastly, based on mammalian
conservation data, we found that eeSNPs are more conserved
than control SNPs (Supplementary Fig. 13).
Discussion
Here we have introduced a novel Bayesian approach, eQTeL, that
integrates genetic and epigenetic data in a statistically consistent
manner to identify putatively causal genetic variants underlying
the expression variance. We have shown that (i) eQTeL identiﬁes
combinations of SNPs (eeSNPs) that, compared with other
methods, explain substantially greater portion of expression
variability, (ii) eQTeL is especially effective in identifying SNPs
with small effect sizes, (iii) 58% of the identiﬁed eeSNPs are likely
to be causal, (iv) eeSNPs can predict sample speciﬁc expression
much more accurately, (v) eeSNPs are much more likely to be
bound by a regulatory factor in an allele-speciﬁc manner,
(vi) eeSNPs preferentially disrupt core cardiac transcription
factor binding and (vii) eeSNPs tend to be spatially proximal to
their target genes. Taken together, our results strongly suggest
that eQTeL captures a substantial proportion of putative
causal regulatory genetic determinants underlying transcriptomic
variance.
It is important to note limitations of eQTeL. First, eQTeL can
only detect cis-eQTL and not trans-eQTL. Second, like other
model-based association methods, eQTeL’s computational speed
is a bottleneck; however, using parallel cores and certain
reasonable compromises in parameter estimation procedure, the
computational burden can be substantially reduced. Third,
eQTeL assumes normality of expression data, therefore the
expression data needs to be pre-processed accordingly,which can
be particularly problematic for certain kinds of high throughput
data. Fourth, eQTeL can only detect SNPs with small effect size if
they have high regulatory potential. Finally, eQTeL statistically
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infers the potentially causal SNPs and further experimental
validations are required to establish causality.
eQTeL can effectively resolve LD and discriminate putative
regulatory SNPs from myriad associated SNPs. This lays a
foundation for future experimental studies to characterize genetic
variants underlying disease risk. Finally, eQTeL can be extended
by integrating additional layer of molecular data—easily achieved
in Bayesian framework—to directly infer SNP that causes disease.
Methods
Modelling regulatory-interaction potential. There are R1 epigenetic features Ei
that were used to predict if a SNP i lies in a regulatory region. In addition, we also
have R2 interaction features Pij that are predictive of the interaction between SNP i
and gene j. We refer to a SNP that has high regulatory potential and high inter-
action potential as interacting-regulator, regardless of whether it associates with
gene expression. Further, if the SNP is associated with gene expression, we refer to
that SNP as expression-regulator. In our eQTeL approach, we model the regulatory-
interaction potential yij between SNP i and gene j as a combined function of
epigenetic features Ei and interaction features Pij. Speciﬁcally, we use a Bayesian
logistic regression model:
yij  Bern logistic Fij  aÞ
 
;

where Fij is a concatenated set of features consisting of both Ei and Pij, and Bern is
the Bernoulli distribution. The coefﬁcients a are shared across all genes.
Modelling gene expression. In our model, the expression of gene j depends not
only on the allele status of candidate SNPs, but also on the estimated regulatory-
interaction potential of the SNP i and gene j pair. Speciﬁcally, given gene
expression in n samples Yj¼ (Yj1,y,Yjn), we model the vector of expression Yj for
gene j as a linear function of the allele status for all candidate SNPs, X¼ {X1,?,
Xp} where Xi is allele status of SNP i over the n samples:
Yj bj;X; cj
  N Xg;j  bg;j;r2j I
 
; ð1Þ
where the effect bij of SNP i on the expression of gene j is non-zero only when
indicator variable gij¼ 1. In other words, gij¼ 1 signiﬁes whether SNP i is
associated with the expression of gene j. Xc,j (and bc,j) refers to a subset of SNPs for
which gij¼ 1.
If a SNP lies within a genomic region that is deemed to be
(i) a regulator, and (ii) interacting with the target gene, then the SNP is likely to
affect the gene’s expression. Thus, the regulatory-interaction potential for each pair
of SNP i and gene j enters our gene expression model through the prior
distribution on the indicator variables gij,
gij f yij
   Bern f yij   8 SNPs i ð2Þ
where the function f(y) is deﬁned so that f yð Þ ¼ pyp1 y0 ¼ p=r1 y with p being
our prior probability for each SNP to be expression-regulator and let p0¼p/r be
the prior probability when the SNP does not reside in such a region, where r is an
ampliﬁcation factor. An uniform prior for pA(m/e, M/e) is deﬁned, where m and
M are respectively the minimum and the maximum number of expected
expression-regulators. However, no substantial difference in results was observed
when we just ﬁxed p ¼ m=e where m is expected number of expression regulators.
A value of r¼ 100 was used because performance of model was insensitive to
choice of rA(100, 1,000).
Because of severe multiple testing corrections, association studies miss many
potential causal regulators that have relatively small effect on expression. In our
eQTeL model, overall sparsity is controlled by two factors: (a) the fraction of SNPs
which are interacting-regulators, that is, E(y) and (b) the fraction of interacting-
regulators which are expression-regulators, that is, p. This is because the overall
sparsity is a product of the two factors, that is, logE(f(y))EE(y)logp assuming
r4441. Thus, the effective sparsity constraints are less conservative on SNPs that
lie within an interacting-regulator in our eQTeL model, which allows us to capture
potential causal expression-regulator SNPs with small (but non-zero) effects on
expression variance (Fig. 4 and Supplementary Fig. 6; refer to Supplementary
Note 5).
We also employ a standard prior distribution, Zeller’s g-prior20, for our linear
model parameters,
bg c; r; cj  N 0; cs2 XTgXg
  1 
; p s2
  / 1=s2 ð3Þ
and we also deﬁne the following prior distributions for the rest of the parameters as
c  IG 1
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;
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The ﬁrst element of a, a0 is the bias term, and b is the prior for a, and is set to 0,
except for b0 (the prior for a0), which can be used to control the sparsity on the
number of interacting-regulators. We expect 1% of all SNPs to be regulators. To
achieve this level of sparsity in number of regulators, b0 was set to log(e/(p e)),
where e is expected number of interacting-regulators, and was set to p/100. That is,
b0¼ log(1/99).
Refer to Supplementary Note 1 for the eQTeL’s inference algorithm,
initialization and convergence criteria.
Cardiac expression data (MAGNet). Samples of cardiac tissue (n¼ 313)
were acquired from patients from the Myocardial Applied Genomics Network
(MAGNet; www.med.upenn.edu/magnet). Left ventricular free-wall tissue was
harvested at the time of cardiac surgery from subjects with heart failure undergoing
transplantation and from unused donor hearts. Genomic DNA was extracted using
the Gentra Puregene Tissue Kit (Qiagen, CA) according to manufacturer’s
instructions. Total RNA was extracted using the miRNeasy Kit (Qiagen) including
DNAse treatment. RNA concentration and quality was determined using the
NanoVue Plus spectrophotometer (GE Healthcare) and the Agilent 2,100 RNA
Nano Chip (Agilent). To assess gene expression, RNA was hybridized with
Affymetrix Genechip ST1.1 arrays using manufacturer instructions. CEL ﬁles
were normalized with the robust multi-array analysis using the oligo package in
Bioconductor38. To remove potential batch effects, expression values were further
adjusted using ComBat, an empirical Bayes method that estimates parameters for
location and scale adjustment of each batch for each gene independently39. Probe
sets were removed if they displayed robust multi-array analysis expression values
o4.8 on all arrays. This ﬁltering yielded sets of genes present well above
background levels in the human heart. Probeset showing no annotated cross
hybridization potential were kept, leaving 15,395 probes for ﬁnal analysis.
Selection of genes. The genes were selected such that they had at least one
signiﬁcantly associated SNPs based on univariate-eQTL (Matrix eQTL). 1,880
genes were thus selected using FDR threshold of 1E-6 using Matrix-eQTL
(Lappalanien et al.). We have no reason to believe that this selection is favourable
to eQTeL.
Pre-procession of gene-expression. It has been found that removing technical
biases and confounding factors can greatly improve the association studies.
Normalization of gene-expression data to remove confounding factors have been
studied extensively (40,41). In association studies the comparison is across
individual and not across genes, and therefore main aim of the normalization is to
make the gene-expression distribution across samples comparable. Similar to
Lappalainen et al., we use PEER40 to remove the confounding factors from
expression data as pre-processing. Given expression data for multiple individuals,
PEER identiﬁes hidden factors that explain a large proportion of global expression
variability. Factors represent covariates that affect multiple gene and are therefore
most likely to be confounding factors or technical biases. The factors are then
regressed out from the expression and residual are used for performing association
studies. In certain cases, such in trans-eQTL, a genetic-factor can affect multiple
SNPs and PEER might remove biologically relevant signal. However, since the aim
of the paper is to identify cis-eQTL, that is, local effects, we can safely use PEER.
To determine number of factors (K) to be removed using PEER, we used
approach similar to Lappalaninen et al. We ran PEER for 16,271 Affymetrix gene
probes from MagNet using parameter K¼ 0, 3, 5, 10, 15 and 20; then we compared
number of genes (eGenes) that have at least one SNPs signiﬁcantly associated with
expression (P valueo1 10 6). We chose K¼ 10 because number of eGenes
plateaued at K¼ 10. Factors from PEER were regressed out from the expression
and residual expression was used for further analyses.
Linear regression assumes normality of the expression data. We converted the
residual data from PEER to standard normal distribution before performing the
association analysis.
Genotypes and imputation for cardiac samples. DNA samples were genotyped
using Affymetrix Genome Wide SNP Array 6.0 and analysed per manufactures
instructions. We applied quality control (QC) ﬁlters to exclude unreliable samples,
samples with cryptic relatedness and samples that were not genetically inferred
Caucasian. After QC ﬁltering, 313 individuals remained. All analyses were
conducted using software package PLINK14. For the analysis reported here,
we eliminated SNPs with genotype call rate o95%, with minor allele frequency
(MAF) o 15%, or if there was signiﬁcant departure from Hardy–Weinberg
equilibrium (Po10 6). A total of 360,046 SNPs passed QC and were available for
analysis. To improve cross study comparisons, genotype imputation was performed
using the Minimac (v 2012.11.16) (ref. 27) program. Imputation results were
ﬁltered at an imputation quality threshold of 0.5 and a MAF threshold of 0.15.
PLINK14 was used to infer LD block for the genotypes. Default setting of SNPs
within 200 Kb was used to estimate it.
Epigenetic data and interaction features. Epigenetic data were obtained from
ENCODE, Roadmap epigenome project and GEO database for following heart
tissues: AoAF, HCM, HCF, fetal-hearts, adult-hearts, left ventricle, right ventricle,
arota, and right atrium. Because DNAse I footprints were used to validate eeSNPs,
they were excluded from the feature importance (a) estimation of eQTeL.
Supplementary Fig. 2 lists the epigenetic and interaction features, that were critical
for identiﬁcation of interacting-regulators. We assessed the importance of epige-
netic factors directly overlapping each SNP within 50 bps ﬂanking region (sufﬁx .50
in Supplementary Fig. 2). We also assessed the importance of epigenetic factors in
broader context of each SNP within 500 bps ﬂanking region (sufﬁx .500 in
Supplementary Fig. 2). Interaction features between a gene-promoter and a region
containing SNP were calculated using RNASeq and DHS data from 15 cell types
(A549, Bj, H1hesc, Hepg2, Hsmm, K562, Nhek, Ag04450, Gm12878, Helas3,
Hmec, Huvec, Mcf7, Nhlf and Sknshra). These features include: (a)correlation and
absolute correlation between DHS of the region and DHS of the promoter (b)
correlation and absolute correlation between DHS of the region and RNASeq
FPKM of the gene.
Both epigenetic and interaction features were normalized to mean of 0 and
standard deviation of 1. This implies that distribution of each of these features for a
set of random SNPs were expected to have 0 mean and 1 s.d. Therefore, y axis
in Supplementary Fig. 2 shows absolute enrichment over random-SNPs with
units in s.d.
Estimating fraction of putatively causal eeSNP. Using an approach similar to
Lappalanien et al.11, we estimated proportion of eeSNP that are putatively causal.
Clearly, an independent estimation of proportion of causal SNPs cannot rely on
features used to identify eeSNPs, or any other potentially correlated feature, such as
footprints. Thus, for an independent estimate of the proportion of causal SNPs, we
used potential TF binding disruption by a SNP allele. Following Lappalanien et al.,
using Matrixeqtl25, we ﬁrst identiﬁed causal SNPs as follows. For each gene we
identiﬁed best and second best associated SNPs, and the best SNP was deemed
causal if (i) the best SNP association was signiﬁcant (FDRo10 6) and (ii) the
difference in association score ( log10 P value) between the best and the second
best SNPs was greater than a threshold (conservatively, 2.5, a la Lappalanien et al.).
For each TF motif, we obtained the disruption at each SNP (decrease in motif
match scores due minor allele relative to major allele) thus obtaining two
distributions, one for causal SNPs and another for the presumed non-functional
background. Using distribution of motif disruption score for causal SNP, we
identiﬁed TF motifs that are preferentially disrupted by causal SNPs. For each of
such motif y, we calculated an enrichment score ccausal,y which is the ratio of means
of TF motif disruption score between the causal and a set of presumed non-causal
SNPs. For motif y, we similarly calculated the enrichment score for eeSNPs ceeSNP,y.
Following Lappalainen et al., we then estimated the fraction of eeSNPs likely to be
causal as ceeSNP;y  1ccausal;y  1. Supplementary Fig. 14 shows these proportion of eeSNP that is
likely to be causal for all selected motifs, suggesting that overall 58% of eeSNPs are
putatively causal.
Functional explained variance and expression predictability was deﬁned as
explained variance by subset of expression-regulators that mapped to a DNAse I
footprint.
Simulation study. Simulation was done on 200 genes. We used 174,800 SNPs
(874 SNPs per each gene) for 313 samples from MAGNet genotype data. 1% of
total SNPs were declared as enhancers. We estimated, number of causal regulatory
SNPs and distribution of explained expression variance by genotype by running
eQTeL in MAGNet data. Using estimated number of causal regulators from
MAGNet, expression-regulators were selected among enhancer per gene. Effect-
size of each expression regulator was generated from N 0; 1ð Þ, that is ﬁnally being
used to generate expression for each gene using a linear model. Finally a random
noise was added such that explained variance by expression-regulators will be same
as estimated from MAGNet data. For each regulator SNP, seven epigenetic features
(DNAse, H3K4me1, H3K4me3, P300, H3K27me3, H3K36me3 and H3K9me3) for
heart were generated from distribution derived from validated heart enhancers6.
For all other SNPs epigenetic features were generated from random SNP
background.
Motif binding score differential. For each of the 981 vertebrate TF motif from
TRANSFAC database42, we scanned the 50 bps ﬂanking eeSNPs (and for 10,000
control SNPs randomly sampled from 300,000 SNPs) for the presence of motif
using pwmscan tool43, separately for the major and the minor allele. Only the cases
where at one of the two alleles had a motif hits (P valueo0.0002) were further
considered. For each such case, the difference in the binding score for the two
alleles was computed, as the difference in log(P value). For each motif, the binding
differential score for eeSNPs and the control SNPs were compared using Wilcoxon
test and the motifs which had at least 1.5-fold greater differential among eSNPs and
a P valueo0.05 were identiﬁed.
DNAse footprint enrichment. From31 we obtained a list of genomic locations, for
41 different cell-types, where signiﬁcant evidence of in vitro protein binding event
were detected using DNAse-footprint. For each tissue, we calculated fraction of
number of SNP that have a footprint in the 50 bps ﬂanking it.
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Allelic imbalance and ChIA-PET analysis. DNAse hypersensitivity (DHS-seq)
reads for heart cells (HCM sample) were obtained and mapped to eeSNPs (and
control SNPs). Heterozygousity at each SNP locus was ascertained by the presence
of multiple alleles among the reads mapping to the SNP location. For each such
locus, the allelic imbalance was calculated as
the difference in the number of reads mapped to each allele.
The allelic imbalance was plotted against the overall signal intensity rank.
ChIA-pet assay identiﬁed spatially proximal genomic regions where at least one
of the region is bound by PolII. Because
ChiA-pet data is unavailable for heart-related cell types, we pooled multiple ChiA-
pet data from K562, Hela, Nb4 and MCF7. For each 50 bps ﬂanking an eeSNP (or
control SNP) and the target promoter pair, number of ChIA-pet reads supporting
the spatial proximity of the two loci were recorded. The ChiA-pet support for each
SNP-gene pair was then compared for different methods after controlling for the
genomic distance between the SNP and its target gene.
In Figs 6 and 7, median ‘white’ lines represent LOESS (local regression) for each
method. Conﬁdence interval for each median line is estimated using bootstrapping
and they are shown in the s using either of following two ways: by thin lines
representing LOESS of each bootstrap, or by coloured regions representing
conﬁdence intervals in terms of standard deviation of bootstraps.
Software availability. The implementation of eQTeL with its source code is freely
available at (www.cbcb.umd.edu/software/goal) as a R-package under MIT license.
For details of other eQTL methods (Supplementary Note 3); expression
explained variance and predictability (Supplementary Note 6); and scalability of
eQTeL (Supplementary Note 7) refer to Supplementary Notes.
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